查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1571997

经皮冠状动脉介入治疗 (PCI) 设备的全球市场

Percutaneous Coronary Intervention (PCI) Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，美国经皮冠状动脉介入治疗 (PCI) 设备的全球市场预计将达到 138 亿美元

经皮冠状动脉介入治疗(PCI) 设备的全球市场预计到2023 年将达到93 亿美元，预计在2023 年至2030 年分析期间将以5.8% 的复合年增长率增长，到2030 年将达到138 亿美元。冠状动脉支架是本报告分析的细分市场之一，复合年增长率为 5.1%，预计到分析期结束时将达到 54 亿美元。分析期间 PTCA 导管段的复合年增长率预计为 7.3%。

美国市场预计成长25亿美元，中国复合年增长率5.5%

预计 2023 年美国经皮冠状动脉介入治疗 (PCI) 设备市场规模将达到 25 亿美元。中国作为世界第二大经济体，预计2030年市场规模将达22亿美元，2023-2030年分析期间复合年增长率为5.5%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 4.9% 和 4.9%。在欧洲，德国的复合年增长率预计为 4.5%。

全球经皮冠状动脉介入 (PCI) 设备市场 - 主要趋势和驱动因素总结

技术创新将如何改变PCI设备？

由于旨在提高冠状动脉疾病治疗的安全性和有效性的技术创新，经皮冠状动脉介入治疗（PCI）设备市场正在经历重大转变。 PCI 是一种用于打开狭窄冠状动脉的微创手术，依赖多种设备，包括支架、导管和球囊血管成形术。技术的进步促进了药物释放型支架 (DES) 的发展，它可以释放药物来防止血管再阻塞（动脉血管再阻塞），与裸金属支架相比，可显着改善长期预后。此外，随着时间的推移而溶解的生物可吸收支架也成为一种有前景的选择，有可能减少长期併发症。其他创新，例如光同调断层扫瞄(OCT) 和血管内超音波(IVUS) 等血管内成像技术，可实现动脉的精确可视化，从而实现更精确的支架放置并改善手术过程。机器人辅助 PCI 的出现也势头强劲，可提高复杂手术过程中的精确度并减少操作员的疲劳。这些技术进步使 PCI 设备更加有效且对患者更友好，从而使其在世界各地的医疗保健系统中得到越来越多的采用。

为什么 PCI 设备在冠状动脉疾病的治疗中变得至关重要？

由于人口老化、久坐的生活方式以及糖尿病和高血压的增加等因素，冠状动脉疾病（CAD）的盛行率不断增加，对 PCI 设备的需求显着增加。 PCI 手术为传统冠状动脉绕道手术手术 (CABG) 手术提供了一种侵入性较小的替代方案，可缩短恢復时间并降低併发症风险。 PCI 的高成功率，加上支架技术和导管设计的进步，使其成为稳定型心绞痛和心臟病等急性冠状动脉症候群的首选治疗选择。此外，心导管实验室的增加和熟练的介入性心臟病专家的数量进一步推动了 PCI 设备的采用。随着医疗保健提供者致力于改善心血管疾病患者的治疗效果，PCI 设备将在CAD 的管理和治疗中发挥越来越重要的作用，特别是对于高风险患者或不适合进行心臟直视手术的患者。

监管核准和市场动态如何影响 PCI 设备市场？

监管核准和不断发展的医疗保健政策正在显着影响 PCI 设备市场。美国食品药物管理局(FDA) 和欧洲药品管理局 (EMA) 等严格的监管要求确保 PCI 设备在核准临床使用之前满足高安全性和有效性标准。最近核准的新一代药物释放型支架和生物可吸收血管支架进一步推动了市场成长，因为这些设备可以改善预后并降低併发症发生率。此外，对基于价值的医疗保健的日益关注正在影响医院和心臟中心采用 PCI 设备，这不仅可以改善临床结果，还可以降低长期医疗保健成本。对微创手术的日益重视也为製造商开发和销售创新 PCI 设备创造了机会。设备製造商和医疗保健提供者之间进行临床试验和开发最尖端科技的合作正在加快这个竞争激烈的市场中产品创新的步伐。

推动PCI设备市场成长的因素有哪些？

经皮冠状动脉介入治疗（PCI）设备市场的成长是由技术进步、冠状动脉疾病盛行率上升以及医疗基础设施投资增加等多种因素所推动的。关键驱动因素之一是药物释放型支架、生物可吸收支架和改进的导管技术的不断发展，这些技术大大提高了 PCI 手术的有效性。此外，全球心血管疾病负担，特别是在老龄化社会以及肥胖和糖尿病发病率不断上升的地区，导致对微创冠状动脉介入治疗的需求不断增加。对先进医疗设备的监管支援以及心导管实验室的增加正在扩大 PCI 手术在已开发市场和新兴市场的可用性。此外，向以改善患者治疗结果和降低医疗成本为重点的基于价值的医疗模式的转变正在推动医院和诊所采用先进的 PCI 技术。随着对冠状动脉疾病的侵入性较小、更有效的治疗方法的需求持续增长，PCI 设备市场预计将持续成长。

全球射孔枪市场－主要趋势与驱动因素总结

科技进步如何影响射孔枪市场？

技术进步在提高油气井钻探效率和精确度方面发挥关键作用，彻底改变了钻枪市场。钻枪是完井过程中使用的关键工具，它在井孔和储层之间创建隧道，使石油和天然气流入井眼。先进的聚能射孔弹、电子起爆系统和可寻址开关等创新大大提高了钻井作业的效率和安全性。先进的装药几何形状可以钻出更深、更干净的孔，提高油井生产率，同时最大限度地减少对地层的损害。此外，电子穿孔系统取代了传统的机械系统，从而提高了可靠性、精确时间和爆炸过程的即时控制。这些系统降低了意外爆炸的风险，并允许在一次操作中钻多个区域，从而优化操作效率。此外，枪枝设计的创新，包括模组化和可重复使用的钻枪，正在降低营运成本并提高完井的环境永续性。这些进步正在推动穿孔枪在陆上和海上钻井作业的采用。

为什么穿孔枪在石油和天然气产业很重要？

射孔枪在石油和天然气工业中发挥重要作用，可以有效地从储存中提取碳氢化合物。钻完井眼后，用钻枪穿透套管和水泥，形成一条将井孔与油气储存连接起来的沟槽。这个过程对于促进碳氢化合物流动和最大限度地提高油井产能至关重要。穿孔枪的多功能性使其对于传统和非常规钻井作业（包括页岩地层中的水力压裂）至关重要。对于钻井条件更为严苛的海上作业，专为高压高温 (HPHT) 环境设计的穿孔枪可确保可靠的性能和安全性。随着全球对石油和天然气的需求不断增加，特别是在新兴经济体，对高效且具有成本效益的钻井技术（例如先进的穿孔枪）的需求也在增加。穿孔枪不仅对于优化生产至关重要，而且在减少停机时间和提高油井作业的整体经济效益方面也发挥关键作用。

产业趋势与环境因素如何影响穿孔枪市场？

行业趋势，特别是对成本效率和环境永续性的日益关注，正在塑造穿孔枪市场的未来。石油和天然气公司越来越多地寻求穿孔技术，以提高油井生产率，同时减少对环境的影响。因此，对可重复使用的模组化钻枪的需求不断增长，这些钻枪可以多次部署，减少废弃物并降低营运成本。此外，高性能定形炸药的进步最大限度地减少了钻井过程中炸药的使用量，有助于减少完井时的环境足迹。石油和天然气作业向数位化和自动化的转变也正在影响市场，电子雷管系统由于其准确性、可靠性以及与其他地下技术整合的能力而变得越来越受欢迎。此外，水平钻井和水力压裂等非常规钻井技术的日益采用，增加了对能够处理复杂井几何形状和高压的先进钻井系统的需求。随着环境法规变得更加严格，业界对永续和高效钻井解决方案的关注将继续增长。

推动射孔枪市场成长的因素有哪些？

钻枪市场的成长受到多种因素的推动，例如技术进步、全球石油和天然气需求的增加以及非常规钻井作业的扩张。主要驱动力之一是先进钻井技术的发展，以提高油井产能和作业效率。越来越多采用电子起爆系统和可重复使用的钻枪也有助于市场成长，因为这些技术降低了成本并提高了完井过程中的安全性。此外，世界各地向非常规钻井方法（例如页岩地层中的水力压裂）的转变，正在推动对能够应对复杂井眼环境的高性能穿孔枪的需求。对环境永续性的日益关注以及遵守更严格法规的需求促使石油和天然气公司采用穿孔系统，以最大限度地提高资源开采率，同时最大限度地减少对环境的影响。随着能源产业的不断发展，在这些技术、环境和营运趋势的推动下，穿孔枪市场预计将扩大。

受访企业范例（44家知名企业）

  • Abbott Laboratories
  • AMG International
  • Asahi Intecc Co., Ltd.
  • B. Braun Melsungen AG
  • Biosensors International Group Ltd.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • BrosMed Medical Co., Ltd.
  • Claret Medical
  • Comed BV
  • Contego Medical, LLC
  • Cordis Corporation
  • Elixir Medical Corporation
  • EPflex Feinwerktechnik GmbH
  • GaltNeedleTech
  • Lepu Mdicial Technology（Beijing）Co., Ltd
  • Medtronic PLC
  • Meril Life Sciences Pvt., Ltd.
  • Merit Medical Systems, Inc.
  • OptiMed Medizinische Instrumente GmbH
  • OrbusNeich
  • Penumbra, Inc.
  • RONTIS
  • SP Medical A/S
  • Stentys SA
  • Teleflex Inc.
  • Terumo Medical Corporation

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP13911

Global Percutaneous Coronary Intervention (PCI) Devices Market to Reach US$13.8 Billion by 2030

The global market for Percutaneous Coronary Intervention (PCI) Devices estimated at US$9.3 Billion in the year 2023, is expected to reach US$13.8 Billion by 2030, growing at a CAGR of 5.8% over the analysis period 2023-2030. Coronary Stents, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$5.4 Billion by the end of the analysis period. Growth in the PTCA Catheters segment is estimated at 7.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.5 Billion While China is Forecast to Grow at 5.5% CAGR

The Percutaneous Coronary Intervention (PCI) Devices market in the U.S. is estimated at US$2.5 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$2.2 Billion by the year 2030 trailing a CAGR of 5.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.9% and 4.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global Percutaneous Coronary Intervention (PCI) Devices Market – Key Trends & Drivers Summarized

How Are Technological Innovations Transforming PCI Devices?

The percutaneous coronary intervention (PCI) devices market has undergone remarkable transformation, driven by technological innovations aimed at improving the safety and efficacy of coronary artery disease treatments. PCI, a minimally invasive procedure used to open narrowed coronary arteries, relies on a variety of devices such as stents, catheters, and balloon angioplasty. Technological advancements have led to the development of drug-eluting stents (DES), which release medication to prevent restenosis (re-narrowing of the arteries), significantly improving long-term outcomes compared to bare-metal stents. Additionally, bioresorbable stents, which dissolve over time, are emerging as a promising alternative, offering the potential to reduce long-term complications. Other innovations, such as intravascular imaging technologies like optical coherence tomography (OCT) and intravascular ultrasound (IVUS), allow for precise visualization of the arteries, enabling more accurate stent placement and reducing procedural risks. The advent of robotics-assisted PCI is also gaining momentum, offering enhanced precision and reduced operator fatigue during complex procedures. These technological advancements are making PCI devices more effective and patient-friendly, thereby driving adoption across healthcare systems globally.

Why Are PCI Devices Becoming Crucial in the Treatment of Coronary Artery Disease?

The growing prevalence of coronary artery disease (CAD), driven by factors such as aging populations, sedentary lifestyles, and rising incidences of diabetes and hypertension, has significantly increased the demand for PCI devices. PCI procedures offer a less invasive alternative to traditional coronary artery bypass graft (CABG) surgery, reducing recovery times and lowering the risk of complications. The high success rates of PCI, coupled with advancements in stent technology and catheter design, have made it a preferred treatment option for both stable angina and acute coronary syndromes like heart attacks. Furthermore, the increasing number of cardiac catheterization labs and the rise in skilled interventional cardiologists worldwide are further boosting the adoption of PCI devices. As healthcare providers focus on improving outcomes for patients with cardiovascular diseases, PCI devices are playing an increasingly critical role in managing and treating CAD, particularly in patients who are high-risk or not ideal candidates for open-heart surgery.

How Are Regulatory Approvals and Market Dynamics Influencing the PCI Devices Market?

Regulatory approvals and evolving healthcare policies are significantly shaping the PCI devices market. Stringent regulatory requirements from agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) ensure that PCI devices meet high standards for safety and efficacy before they are approved for clinical use. Recent approvals of newer-generation drug-eluting stents and bioresorbable vascular scaffolds are further driving market growth, as these devices offer improved outcomes and reduced complication rates. In addition, the rising focus on value-based healthcare is influencing hospitals and cardiology centers to adopt PCI devices that not only improve clinical outcomes but also reduce long-term healthcare costs. The growing emphasis on minimally invasive procedures is also creating opportunities for manufacturers to develop and market innovative PCI devices. Collaborations between device manufacturers and healthcare providers, aimed at conducting clinical trials and developing cutting-edge technologies, are accelerating the pace of product innovation in this competitive market.

What Factors Are Driving Growth in the PCI Devices Market?

The growth in the percutaneous coronary intervention (PCI) devices market is driven by several factors, including technological advancements, the rising prevalence of coronary artery disease, and increasing healthcare infrastructure investments. One of the primary drivers is the ongoing development of drug-eluting stents, bioresorbable stents, and improved catheter technologies, which are significantly enhancing the effectiveness of PCI procedures. Additionally, the global burden of cardiovascular diseases, particularly in aging populations and regions with increasing rates of obesity and diabetes, is leading to higher demand for minimally invasive coronary interventions. Regulatory support for advanced medical devices, along with the growing number of cardiac catheterization labs, is expanding the accessibility of PCI procedures in both developed and emerging markets. Moreover, the shift toward value-based healthcare models, which focus on improving patient outcomes and reducing healthcare costs, is prompting hospitals and clinics to adopt advanced PCI technologies. As the demand for less invasive, more effective treatments for coronary artery disease continues to rise, the PCI devices market is expected to experience sustained growth.

Global Perforating Guns Market – Key Trends & Drivers Summarized

How Are Technological Advancements Impacting the Perforating Guns Market?

Technological advancements are playing a crucial role in revolutionizing the perforating guns market, making oil and gas well perforation more efficient and precise. Perforating guns, essential tools used in well-completion processes, create tunnels between the wellbore and the reservoir, allowing oil or gas to flow into the well. Innovations such as advanced-shaped charges, electronic detonation systems, and addressable switches have significantly improved the efficiency and safety of perforation operations. Advanced-shaped charges are now capable of producing deeper and cleaner perforations, enhancing well productivity while minimizing formation damage. Additionally, electronic perforating systems have replaced traditional mechanical ones, offering improved reliability, precise timing, and real-time control over the detonation process. These systems reduce the risk of misfires and allow for multi-zone perforation in a single run, optimizing operational efficiency. Moreover, innovations in gun design, including modular and reusable perforating guns, are lowering operational costs and increasing the environmental sustainability of well completions. These advancements are driving greater adoption of perforating guns in both onshore and offshore drilling operations.

Why Are Perforating Guns Critical in the Oil and Gas Industry?

Perforating guns play a critical role in the oil and gas industry by enabling the efficient extraction of hydrocarbons from reservoirs. After a well has been drilled, perforating guns are used to penetrate the casing and cement to create channels that connect the wellbore to the oil or gas reservoir. This process is vital for enhancing the flow of hydrocarbons and maximizing well productivity. The versatility of perforating guns makes them indispensable for both conventional and unconventional drilling operations, including hydraulic fracturing (fracking) in shale formations. In offshore operations, where drilling conditions are more challenging, perforating guns designed for high-pressure, high-temperature (HPHT) environments ensure reliable performance and safety. As global demand for oil and gas continues to rise, particularly in emerging economies, the need for efficient and cost-effective well-completion technologies, such as advanced perforating guns, is also increasing. Perforating guns are not only essential for optimizing production but also play a key role in reducing downtime and improving the overall economics of well operations.

How Are Industry Trends and Environmental Considerations Shaping the Perforating Guns Market?

Industry trends, particularly the growing focus on cost-efficiency and environmental sustainability, are shaping the future of the perforating guns market. Oil and gas companies are increasingly seeking perforating technologies that enhance well productivity while reducing environmental impact. As a result, there is growing demand for reusable and modular perforating guns that can be deployed multiple times, reducing waste and lowering operational costs. Additionally, advancements in high-performance shaped charges are minimizing the amount of explosives used during perforation, which helps reduce the environmental footprint of well completions. The shift toward digitalization and automation in oil and gas operations is also influencing the market, with electronic detonation systems becoming more popular due to their precision, reliability, and ability to integrate with other downhole technologies. Furthermore, the rising adoption of unconventional drilling techniques, such as horizontal drilling and fracking, is driving demand for advanced perforating systems that can handle complex well geometries and high pressures. As environmental regulations become stricter, the industry’s focus on sustainable and efficient perforating solutions will continue to grow.

What Factors Are Driving Growth in the Perforating Guns Market?

The growth in the perforating guns market is driven by several factors, including technological advancements, increasing global demand for oil and gas, and the expansion of unconventional drilling operations. One of the main drivers is the development of advanced perforating technologies that improve well productivity and operational efficiency. The rising adoption of electronic detonation systems and reusable perforating guns is also contributing to market growth, as these technologies reduce costs and improve safety during well completions. Additionally, the global shift toward unconventional drilling methods, such as hydraulic fracturing in shale formations, is fueling demand for high-performance perforating guns capable of handling complex well environments. The growing focus on environmental sustainability and the need to comply with stricter regulations are prompting oil and gas companies to invest in perforating systems that minimize environmental impact while maximizing resource extraction. As the energy industry continues to evolve, the perforating guns market is expected to expand, driven by these technological, environmental, and operational trends.

Select Competitors (Total 44 Featured) -

  • Abbott Laboratories
  • AMG International
  • Asahi Intecc Co., Ltd.
  • B. Braun Melsungen AG
  • Biosensors International Group Ltd.
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • BrosMed Medical Co., Ltd.
  • Claret Medical
  • Comed B.V.
  • Contego Medical, LLC
  • Cordis Corporation
  • Elixir Medical Corporation
  • EPflex Feinwerktechnik GmbH
  • GaltNeedleTech
  • Lepu Mdicial Technology (Beijing) Co., Ltd
  • Medtronic PLC
  • Meril Life Sciences Pvt., Ltd.
  • Merit Medical Systems, Inc.
  • OptiMed Medizinische Instrumente GmbH
  • OrbusNeich
  • Penumbra, Inc.
  • RONTIS
  • SP Medical A/S
  • Stentys SA
  • Teleflex Inc.
  • Terumo Medical Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Percutaneous Coronary Intervention (PCI) Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cardiovascular Diseases (CVD) Drives Growth in Percutaneous Coronary Intervention (PCI) Devices Market
    • Technological Advancements in Drug-Eluting Stents (DES) Improve Long-Term Outcomes and Spur Market Growth
    • Increasing Adoption of Minimally Invasive Procedures Propels Demand for PCI Devices in Cardiac Interventions
    • Rising Use of Bioresorbable Stents Expands Market for Innovative, Temporary PCI Devices
    • Technological Innovations in Intravascular Imaging Systems (OCT and IVUS) Enhance Precision in PCI Procedures
    • Growing Focus on Robotic-Assisted PCI Systems Strengthens the Business Case for High-Precision Cardiac Interventions
    • Increased Demand for Next-Generation Balloon Catheters Expands Market for Advanced PCI Tools
    • Rising Adoption of PCI Devices in Treating Acute Coronary Syndromes (ACS) Expands Clinical Applications
    • Technological Advancements in Antithrombotic Devices and Drug-Coated Balloons Improve PCI Outcomes
    • Growing Focus on Outpatient and Ambulatory PCI Procedures Expands Market for Less Invasive Cardiac Devices
    • Rising Geriatric Population and High Prevalence of Coronary Artery Disease (CAD) Drive PCI Market Growth
    • Growing Emphasis on Personalized and Precision Medicine Fuels Development of Customized PCI Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Percutaneous Coronary Intervention (PCI) Devices Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Coronary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Coronary Stents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Coronary Stents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for PTCA Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for PTCA Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for PTCA Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Catheterization Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Catheterization Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Catheterization Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Percutaneous Coronary Intervention (PCI) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Product - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Other Products for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Catheterization Labs for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Product - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Other Products for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Catheterization Labs for the Years 2014, 2024 & 2030
  • JAPAN
    • Percutaneous Coronary Intervention (PCI) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Product - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Other Products for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Catheterization Labs for the Years 2014, 2024 & 2030
  • CHINA
    • Percutaneous Coronary Intervention (PCI) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Product - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Other Products for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Catheterization Labs for the Years 2014, 2024 & 2030
  • EUROPE
    • Percutaneous Coronary Intervention (PCI) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Product - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Other Products for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Catheterization Labs for the Years 2014, 2024 & 2030
  • FRANCE
    • Percutaneous Coronary Intervention (PCI) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Product - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Other Products for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Catheterization Labs for the Years 2014, 2024 & 2030
  • GERMANY
    • Percutaneous Coronary Intervention (PCI) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Product - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Other Products for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Catheterization Labs for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Product - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Other Products for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Catheterization Labs for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Percutaneous Coronary Intervention (PCI) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Product - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Other Products for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Catheterization Labs for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 82: Rest of Europe 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Product - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Other Products for the Years 2014, 2024 & 2030
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Catheterization Labs for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Percutaneous Coronary Intervention (PCI) Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 88: Asia-Pacific 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Product - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Other Products for the Years 2014, 2024 & 2030
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Catheterization Labs for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Percutaneous Coronary Intervention (PCI) Devices by Product - Coronary Stents, PTCA Catheters and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of World 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by Product - Percentage Breakdown of Value Sales for Coronary Stents, PTCA Catheters and Other Products for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Hospitals, Ambulatory Surgery Centers and Catheterization Labs Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Percutaneous Coronary Intervention (PCI) Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Catheterization Labs for the Years 2014, 2024 & 2030

IV. COMPETITION